A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 15 February 2019 |
| Author/s |
author: Michael Thomas Mariola Fotin-Mleczek Alexander Knuth Karl-Josef Kallen Ulrike Gnad-Vogt Ingmar Hoerr Sven D Koch |
| Publication date | February 15, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |